Rallybio Corporation Common Stock (RLYB) is a publicly traded Healthcare sector company. As of May 21, 2026, RLYB trades at $14.43 with a market cap of $74.70M and a P/E ratio of -5.06. RLYB moved +2.18% today. Year to date, RLYB is +168.41%; over the trailing twelve months it is +427.04%. Its 52-week range spans $1.76 to $15.31. Rallies surfaces RLYB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Recent RLYB insider activity includes ADAR1 Capital Management, LLC bought 10.00K, ADAR1 Capital Management, LLC bought 200, ADAR1 Capital Management, LLC bought 6.01K, ADAR1 Capital Management, LLC bought 100, and ADAR1 Capital Management, LLC bought 200. Rallies tracks insider transaction dates, shares, prices, and estimated values.
| Metric | Value |
|---|---|
| Price | $14.43 |
| Market Cap | $74.70M |
| P/E Ratio | -5.06 |
| EPS | $-2.84 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.31 |
| 52-Week Low | $1.76 |
| Volume | 66 |
| Avg Volume | 0 |
| Revenue (TTM) | $858.00K |
| Net Income | $-7.82M |
| Gross Margin | 0.00% |
RLYB analyst coverage data. Average price target: $0.00.